Literature DB >> 28657180

4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study.

Barbara Loi1, Mire Zloh1, Maria Antonietta De Luca2, Nicholas Pintori2, John Corkery1, Fabrizio Schifano1.   

Abstract

BACKGROUND: 4,4'-DMAR (4,4'-dimethylaminorex; "Serotoni") is a potent stimulant drug that has recently been associated with a number of fatalities in Europe. Over the last few years, online communities have emerged as important resources for disseminating levels of technical knowledge on novel psychoactive substances.
OBJECTIVE: Analysing the information provided by the fora communities on 4,4'-DMAR use, additionally critical reviewing the available evidence-based literature on this topic.
METHODS: Different website drug fora were identified. A critical review of the existing evidence-based literature was undertaken. Individuation and analysis of qualitative data from the identified website fora were performed.
RESULTS: The combined search results identified six website fora from which a range of qualitative data on recurring themes was collected. These themes included routes of administration and doses; desired effects; adverse effects; comparison with other drugs; association with other drugs; medications self-administered to reverse 4,4'-DMAR action; overall impression; and provision of harm-reduction advice.
CONCLUSIONS: Although being characterized by a number of methodological limitations, the social networks' Web monitoring approach (netnography) may be helpful to better understand some of the clinical and psychopharmacological issues pertaining to a range of novel psychoactive substances, including 4,4'-DMAR, for which only extremely little, if any, scientific knowledge is available.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  4,4′-DMAR; aminorex derivatives; novel psychoactive substances; online fora; psychonauts; stimulants

Mesh:

Substances:

Year:  2017        PMID: 28657180     DOI: 10.1002/hup.2575

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  8 in total

Review 1.  The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online.

Authors:  Caroline Zangani; Fabrizio Schifano; Flavia Napoletano; Davide Arillotta; Liam Gilgar; Amira Guirguis; John M Corkery; Orsola Gambini; Alessandro Vento
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 2.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

3.  Genotoxicological Characterization of (±)cis-4,4'-DMAR and (±)trans-4,4'-DMAR and Their Association.

Authors:  Monia Lenzi; Sofia Gasperini; Veronica Cocchi; Micaela Tirri; Matteo Marti; Patrizia Hrelia
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

Review 4.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780

Review 5.  Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps.

Authors:  Cristina Miliano; Giulia Margiani; Liana Fattore; Maria Antonietta De Luca
Journal:  Brain Sci       Date:  2018-06-29

6.  Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario.

Authors:  Davide Arillotta; Fabrizio Schifano; Flavia Napoletano; Caroline Zangani; Liam Gilgar; Amira Guirguis; John Martin Corkery; Eugenio Aguglia; Alessandro Vento
Journal:  Front Neurosci       Date:  2020-03-18       Impact factor: 4.677

7.  Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances.

Authors:  Valeria Sogos; Paola Caria; Clara Porcedda; Rafaela Mostallino; Franca Piras; Cristina Miliano; Maria Antonietta De Luca; M Paola Castelli
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 8.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.